On June 24, 2019, Propanc Biopharma, Inc. appointed Carlo Campiciano to serve as the Chief Financial Officer and Secretary of the Company and the Chief Financial Officer and Secretary of Propanc PTY LTD, the Company's wholly owned subsidiary (Propanc PTY), effective as of July 1, 2019 (the Effective Date). Mr. Campiciano shall also assume the role of Principal Accounting Officer of the Company. Mr. Campiciano, prior to his appointment as the Company's Chief Financial Officer and Secretary, Mr. Campiciano served as the Chief Financial Officer of MedAdvisor International Pty Ltd. from July 2012 until December 2016, where he was part of the foundation team that launched MedAdvisor in 2012 and since its launch has been key in raising several rounds of capital as well the company's listing on the ASX in December 2015.

Mr. Campiciano also served as Chief Financial Officer for TGA Unlimited Pty Ltd.